TMO Thermo Fisher Scientific Inc.
Healthcare
Price
$599.10
Intrinsic value
$61.31
Buy price
$49.05
Discount
-877.2%
DCF walkthrough
Near-term growth (g1)0.00%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
- Operating CF
- $9,013,000,000.00
- Total debt
- $42,548,998,144.00
- Cash & STI
- $4,064,000,000.00
- Shares out.
- 371,000,000
Overvalued
Intrinsic value$61.33
Buy price (with MOS)$49.07
Current price$599.10
Discount to intrinsic value-876.8%
7-step quality scorecard
ROE quality
LOW- Average ROE
- 13.5%
- Current ROE
- 12.6%
- Minimum ROE
- 12.6%
Debt quality
MODERATE- Debt / Equity
- 0.80x
Moat proxy
MODERATE_PROXYCash-flow reliability
OK- Operating CF / Net income
- 1.29x
Technical chart
Confluence: DOWNTREND (0/3)Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim.
Assumptions & data quality
- Data source
- yfinance
- Growth (g1) source
- min(cfCAGR,revenueCAGR)
- Valuation model
- DCF_OCF
- Debt as % of DCF PV
- 69.4%
- Public economic interest
- 99.8%
These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.